News

Cologuard is indicated to screen adult men and women aged 50 years or older who are at typical average-risk for CRC

The FDA has approved bevacizumab (Avastin) in combination with paclitaxel and cisplatin or paclitaxel and topotecan as a treatment for patients with persistent, recurrent, or metastatic cervical cancer

The deadline for our 2014 grant cycle recently passed, and in the many hundreds of applications received, we heard a similar story: being cancer-free doesn't mean that cancer IS free.

I believe mastering conversation strategies via social media is as essential to today's nursing practice as our stethoscopes and our brain. Why?

The National Pancreas Foundation (NPF) provides hope for those suffering from pancreatitis and pancreatic cancer through funding cutting-edge research, advocating for new and better therapies, and providing support and education for patients, caregivers, and healthcare professionals.

According to researchers at the University of Washington, the benefits of mammography extend to women older than 75 years, and the findings have the potential to change public health recommendations for breast cancer screening.

A growing understanding of the biological pathways at work in the development of oral mucositis in patients treated with cytotoxic cancer therapies has helped spur interest in steering symptom management away from "institutional folklore" rinses and anecdotal approaches toward evidence-based strategies

The FDA has approved Cologuard as the first noninvasive stool-based DNA test for the detection of colorectal cancer (CRC) in asymptomatic individuals at average risk, based on clinical trial results demonstrating superiority to the fecal immunochemical test (FIT).

A new study has found that postmenopausal women who undertook regular physical activity equivalent to at least 4 hours of walking per week in the last 4 years had a lower risk for invasive breast cancer compared with women who exercised less during those 4 years.

In this podcast, Brian Wojciechowski, MD, Breastcancer.org medical adviser, discusses some of the research that was published in July 2014.

Women harboring a loss-of-function mutation in the PALB2 gene demonstrated an increased risk of developing breast cancer that was similar to the predisposition seen with mutations in the infamous BRCA gene, according to a study published in The New England Journal of Medicine (NEJM).

According to a new study by the American Association for Cancer Research (AACR), nearly 1 in 10 cancer survivors continue to smoke despite the risk of secondary and additional primary cancers.

Several new genetic risk markers in pancreatic cancer have been found, scientists at the Dana-Farber Cancer Institute announced.

When the US Preventive Services Task Force (USPSTF) recommended last year that asymptomatic, high-risk individuals should receive annual screening for lung cancer with low-dose computed tomography (LDCT), it made a healthy decision for the American population.

A new study has found that standardizing prescribing practices for single-fraction radiation therapy (SFRT) for palliation of bone metastases may result in cost savings and an improvement in patients' quality of life.

The Addario Lung Cancer Medical Institute (ALCMI) today launched a new study, the Genomics of Young Lung Cancer, to understand why lung cancer occurs in young adults, who quite often are athletic, never smokers and do not exhibit any of the known lung cancer genetic mutations.

Researchers in Taiwan have found an increase in the risk for head and neck cancers among patients with diabetes mellitus (DM).

Two studies suggest that they do.

Five novel agents for the treatment of patients with advanced squamous cell carcinoma of the lung will be evaluated in the recently launched Lung-MAP trial, an innovative biomarker-driven study that aims to improve the drug development process while exploring therapeutic options for this challenging malignancy.

According to a new study, most women aged 65 and older with non-metastatic breast cancer adhered to their hormone therapy.

A new study led by researchers at the Perelman School of Medicine at the University of Pennsylvania has shown that electroacupuncture produces significant improvements in fatigue, anxiety, and depression in as little as 8 weeks for early-stage breast cancer patients experiencing joint pain related to the use of aromatase inhibitors (AIs).

Genetics may be to blame for an increase in the number of young men diagnosed with prostate cancer, researchers say.

New two drug oral regimen found to be superior to a commonly used regimen.

Researchers now have a better idea of how a mismatch in the DNA repair protein can lead to the development of colorectal cancer.

Rick Bulifant shares his bladder cancer story

Taking the breast cancer journey with someone who's been "in your shoes"

As the use of electronic patient portals grows, a new study examines the use of these portals by cancer patients, extending the doctor-patient relationship to new boundaries.

It was the cancer diagnosis of Nancy Davenport-Ennis' friend that inspired her to open both the Patient Advocate Foundation and National Patient Advocate Foundation (NPAF) back in 1996